BioSpace News Archive

Drug Development

Oculis announces publication and presentation of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema

Oculis S.A. announces that the Phase 2 DX-211, a randomized, double blinded, multi-center and vehicle controlled clinical trial assessing the safety and efficacy of topical OCS-01 in patients with Diabetic Macular Edema has been published by the Acta Ophthalmologica journal.

September 6, 2022
·
5 min read
Biotech Bay

S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia

S2 Genomics, Inc. announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics’ Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in Norway, Finland, Denmark and Sweden.

September 6, 2022
·
2 min read
Pharm Country

Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September 2022

Helius Medical Technologies, Inc. announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at two upcoming healthcare conferences as follows.

September 6, 2022
·
2 min read
Protalix BioTherapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Protalix BioTherapeutics, Inc. announced that the Company will present at the H.C. Wainwright 24th Annual Global Investment Conference, a hybrid conference.

September 6, 2022
·
3 min read
Business

Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers

Leica Biosystems announced a partnership focused on delivering compatible digital pathology workflow solutions.

September 6, 2022
·
2 min read
Bio NC

Milestone Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Milestone Pharmaceuticals Inc. announced that Joseph Oliveto, President and Chief Executive Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12, 2022 at 12:00 p.m. ET in New York, NY.

September 6, 2022
·
1 min read
Genetown

Lyra Therapeutics to Present at the H.C. Wainwright AnnualGlobal Investment Conference 2022

Lyra Therapeutics, Inc. announced the Company’s participation at the H.C. Wainwright 24th Annual Global Investment Conference.

September 6, 2022
·
5 min read
Bio NC

Labcorp to Speak at the Baird 2022 Global Healthcare Conference

Labcorp, a leading global life sciences company, announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET.

September 6, 2022
·
1 min read
BELLUS Health to Present at the H.C. Wainwright Annual Global Investment Conference 2022

BELLUS Health Inc. announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will present a corporate overview of the Company at the H.C. Wainwright Global Investment Conference.

September 6, 2022
·
5 min read
Genetown

Concert Pharmaceuticals to Present at H.C. Wainwright Annual Global Investment Conference 2022

Concert Pharmaceuticals, Inc. announced that it will participate virtually at the H.C. Wainwright 24th Annual Global Investment Conference, and its presentation will be available beginning at 7:00 a.m. ET on September 12, 2022.

September 6, 2022
·
1 min read